Literature DB >> 26073080

ErbB3 upregulation by the HNSCC 3D microenvironment modulates cell survival and growth.

J O Humtsoe1, E Pham1, R J Louie2, D A Chan2, R H Kramer1.   

Abstract

Head and neck squamous carcinomas (HNSCC) present as dense epithelioid three-dimensional (3D) tumor nests that can mediate signals via the human epidermal growth factor receptor (ErbB) tyrosine kinase family to promote intratumoral survival and growth. We examined the role of the tumor microenvironment on ErbB receptor family expression and found that the status of intercellular organization altered the receptor profile. We showed that HNSCC cells forced into tumor island-like 3D aggregates strongly upregulated ErbB3 at the level of transcription. Not only was the elevated ErbB3 responsive to HRG-β1-induced enhanced signaling mechanism, but also analysis by siRNA-knockdown and kinase inhibitor strategies revealed that the ErbB3/AKT signaling pathway was sufficient to enhance tumor cell survival and growth potential. Elevated ErbB3 expression in the high-density 3D culture system was strongly associated with hypoxia-induced HIF-1α. Hypoxia-regulated ErbB3 expression was mediated by the HIF-1α-binding consensus sequence in the ErbB3 proximal promoter. The findings show that the local 3D tumor microenvironment can trigger reprograming and switching of ErbB family members and thereby influence ErbB3-driven tumor growth.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26073080     DOI: 10.1038/onc.2015.220

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  58 in total

1.  Cell culture: biology's new dimension.

Authors:  Alison Abbott
Journal:  Nature       Date:  2003-08-21       Impact factor: 49.962

2.  Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.

Authors:  Gary K Scott; Andrei Goga; Dipa Bhaumik; Crystal E Berger; Christopher S Sullivan; Christopher C Benz
Journal:  J Biol Chem       Date:  2006-11-16       Impact factor: 5.157

3.  Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis.

Authors:  Jianhong Zuo; Tohru Ishikawa; Shadi Boutros; Zhiqiang Xiao; Joseph O Humtsoe; Randall H Kramer
Journal:  Mol Cancer Res       Date:  2010-02-09       Impact factor: 5.852

4.  Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.

Authors:  Andrea Cavalot; Tiziana Martone; Nicolò Roggero; Gabriele Brondino; Marco Pagano; Giorgio Cortesina
Journal:  Head Neck       Date:  2007-07       Impact factor: 3.147

Review 5.  Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC).

Authors:  Roger B Cohen
Journal:  Cancer Treat Rev       Date:  2013-10-12       Impact factor: 12.111

Review 6.  Overcoming resistance to EGFR inhibitor in head and neck cancer: a review of the literature.

Authors:  Guilherme Rabinowits; Robert I Haddad
Journal:  Oral Oncol       Date:  2012-07-25       Impact factor: 5.337

Review 7.  The ErbB/HER family of protein-tyrosine kinases and cancer.

Authors:  Robert Roskoski
Journal:  Pharmacol Res       Date:  2013-11-20       Impact factor: 7.658

8.  Prognostic significance of ERBB3 overexpression in oral squamous cell carcinoma.

Authors:  S Shintani; T Funayama; Y Yoshihama; R E Alcalde; T Matsumura
Journal:  Cancer Lett       Date:  1995-08-16       Impact factor: 8.679

9.  HER3 signalling is regulated through a multitude of redundant mechanisms in HER2-driven tumour cells.

Authors:  Dhara N Amin; Natalia Sergina; Lionel Lim; Andrei Goga; Mark M Moasser
Journal:  Biochem J       Date:  2012-11-01       Impact factor: 3.857

Review 10.  Experimental anti-tumor therapy in 3-D: spheroids--old hat or new challenge?

Authors:  Juergen Friedrich; Reinhard Ebner; Leoni A Kunz-Schughart
Journal:  Int J Radiat Biol       Date:  2007 Nov-Dec       Impact factor: 2.694

View more
  7 in total

Review 1.  Mechanisms of Receptor Tyrosine-Protein Kinase ErbB-3 (ERBB3) Action in Human Neoplasia.

Authors:  Laurel E Black; Jody F Longo; Steven L Carroll
Journal:  Am J Pathol       Date:  2019-07-25       Impact factor: 5.770

2.  Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling.

Authors:  Nico Jacobi; Rita Seeboeck; Elisabeth Hofmann; Helmut Schweiger; Veronika Smolinska; Thomas Mohr; Alexandra Boyer; Wolfgang Sommergruber; Peter Lechner; Corina Pichler-Huebschmann; Kamil Önder; Harald Hundsberger; Christoph Wiesner; Andreas Eger
Journal:  Oncotarget       Date:  2017-11-17

3.  Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells.

Authors:  Karuna Mittal; Da Hoon Choi; Angela Ogden; Shashi Donthamsetty; Brian D Melton; Meenakshi V Gupta; Vaishali Pannu; Guilherme Cantuaria; Sooryanarayana Varambally; Michelle D Reid; Kristin Jonsdottir; Emiel A M Janssen; Mohammad A Aleskandarany; Ian O Ellis; Emad A Rakha; Padmashree C G Rida; Ritu Aneja
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

4.  Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics.

Authors:  Jessica D Sims; Jan Michael Taguiam; Felix Alonso-Valenteen; Janet Markman; Hasmik Agadjanian; David Chu; Jay Lubow; Ravinder Abrol; Dustin Srinivas; Anjali Jain; Bingchen Han; Ying Qu; Parisa Mirzadehgan; Jae-Youn Hwang; Altan Rentsendorj; Alice Chung; Jenny Lester; Beth Y Karlan; Harry B Gray; Zeev Gross; Armando Giuliano; Xiaojiang Cui; Lali K Medina-Kauwe
Journal:  J Control Release       Date:  2017-12-27       Impact factor: 11.467

5.  Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.

Authors:  Nathan Redlich; Anthony M Robinson; Kwangok P Nickel; Andrew P Stein; Deric L Wheeler; Douglas R Adkins; Ravindra Uppaluri; Randall J Kimple; Brian A Van Tine; Loren S Michel
Journal:  Cell Death Dis       Date:  2018-01-05       Impact factor: 8.469

6.  miR‑148a‑3p regulates alcoholic liver fibrosis through targeting ERBB3.

Authors:  Jie Xiong; Jianbo Ni; Congying Chen; Kezhou Wang
Journal:  Int J Mol Med       Date:  2020-06-23       Impact factor: 4.101

7.  HER3-targeted protein chimera forms endosomolytic capsomeres and self-assembles into stealth nucleocapsids for systemic tumor homing of RNA interference in vivo.

Authors:  Felix Alonso-Valenteen; Sayuri Pacheco; Dustin Srinivas; Altan Rentsendorj; David Chu; Jay Lubow; Jessica Sims; Tianxin Miao; Simoun Mikhael; Jae Youn Hwang; Ravinder Abrol; Lali K Medina Kauwe
Journal:  Nucleic Acids Res       Date:  2019-12-02       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.